214 related articles for article (PubMed ID: 19765808)
1. VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Barfield E; Dutta S; Pua T; Fishman DA
Gynecol Oncol; 2009 Dec; 115(3):414-23. PubMed ID: 19765808
[TBL] [Abstract][Full Text] [Related]
2. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
Dutta S; Wang FQ; Wu HS; Mukherjee TJ; Fishman DA
Gynecol Oncol; 2011 Oct; 123(1):129-37. PubMed ID: 21782227
[TBL] [Abstract][Full Text] [Related]
3. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
So J; Wang FQ; Navari J; Schreher J; Fishman DA
Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
[TBL] [Abstract][Full Text] [Related]
4. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Fisher J; Fishman DA
Gynecol Oncol; 2011 Feb; 120(2):247-55. PubMed ID: 21093894
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
Wang FQ; Smicun Y; Calluzzo N; Fishman DA
Mol Cancer Res; 2006 Nov; 4(11):831-41. PubMed ID: 17114341
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases.
Wang FQ; So J; Reierstad S; Fishman DA
Int J Cancer; 2006 Feb; 118(4):879-88. PubMed ID: 16152587
[TBL] [Abstract][Full Text] [Related]
7. Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.
Adham SA; Sher I; Coomber BL
Lab Invest; 2010 May; 90(5):709-23. PubMed ID: 20195243
[TBL] [Abstract][Full Text] [Related]
8. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
Yu X; Zhang Y; Chen H
BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
[TBL] [Abstract][Full Text] [Related]
9. LPA receptor 2 mediates LPA-induced endometrial cancer invasion.
Hope JM; Wang FQ; Whyte JS; Ariztia EV; Abdalla W; Long K; Fishman DA
Gynecol Oncol; 2009 Jan; 112(1):215-23. PubMed ID: 19019417
[TBL] [Abstract][Full Text] [Related]
10. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
Lee J; Park SY; Lee EK; Park CG; Chung HC; Rha SY; Kim YK; Bae GU; Kim BK; Han JW; Lee HY
Clin Cancer Res; 2006 Nov; 12(21):6351-8. PubMed ID: 17085645
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice.
Li H; Wang D; Zhang H; Kirmani K; Zhao Z; Steinmetz R; Xu Y
Mol Cancer Ther; 2009 Jun; 8(6):1692-701. PubMed ID: 19509252
[TBL] [Abstract][Full Text] [Related]
12. Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells.
Ptaszynska MM; Pendrak ML; Bandle RW; Stracke ML; Roberts DD
Mol Cancer Res; 2008 Mar; 6(3):352-63. PubMed ID: 18337445
[TBL] [Abstract][Full Text] [Related]
13. S1P and LPA have an attachment-dependent regulatory effect on invasion of epithelial ovarian cancer cells.
Smicun Y; Gil O; Devine K; Fishman DA
Gynecol Oncol; 2007 Nov; 107(2):298-309. PubMed ID: 17716713
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
[TBL] [Abstract][Full Text] [Related]
15. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
Zhao Y; Zong ZH; Xu HM
Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
[TBL] [Abstract][Full Text] [Related]
16. Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis.
Sher I; Adham SA; Petrik J; Coomber BL
Int J Cancer; 2009 Feb; 124(3):553-61. PubMed ID: 19004006
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
18. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
[TBL] [Abstract][Full Text] [Related]
20. S1P regulation of ovarian carcinoma invasiveness.
Smicun Y; Reierstad S; Wang FQ; Lee C; Fishman DA
Gynecol Oncol; 2006 Dec; 103(3):952-9. PubMed ID: 16956652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
